Skip to main content

Advertisement

Log in

Tc-99m Diphosphonate as a Potential Radiotracer to Detect Sentinel Lymph Nodes in Patients with Breast Cancer

  • Original Article
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the potential of Tc-99m diphosphonate as a tracer for sentinel lymph node biopsy in breast cancer.

Methods

Lymphoscintigraphs of 35 patients (50.9 ± 10.2 years) with breast cancer were acquired after administering a subareolar intradermal injection of Tc-99m diphosphonate 18 h before surgery. Static images were taken within 15 min (early phase) and 15 h after injection (delayed phase). The lymphoscintigraphic identification rate was defined as the percentage of subjects studied with visible foci at axillae. Sentinel lymph node biopsies were performed using a gamma probe and by blue dye injection. Any node that was radioactive or stained with blue dye was labeled as a sentinel lymph node. Lymph nodes without radioactivity or blue dye staining were defined as non-sentinel lymph nodes. The intraoperative identification rate was defined as the percentage of patients with a radioactive sentinel lymph node. Percentages of lymphoid cells expressing S-100, CD83, and CD1a were compared.

Results

The lymphoscintigraphic identification rate was 94.3% (33/35) during the early phase and 96.9% (31/32) during the delayed phase, whereas the intraoperative identification rate was 94.3% (33/35). The mean percentages of lymphoid cells that stained positively for S-100 or CD83 were lower in sentinel lymph nodes than in non-sentinel lymph nodes (1.5% vs. 9.0% for S-100, and 4.5% vs. 9.3% for CD83, respectively, p = 0.0286). The mean percentages of lymphoid cells in sentinel lymph nodes and non- sentinel lymph nodes expressing CD1a were 3.3% and 7.0%, respectively (p = ns).

Conclusions

Tc-99m diphosphonate can reliably detect regional lymph nodes in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Boxen I (1985) Inadvertent lymphoscintigraphy? Clin Nucl Med 10:25–26

    Article  CAS  PubMed  Google Scholar 

  2. Wilhelm AJ, Mijnhout GS, Franssen EJ (1999) Radiopharmaceuticals in sentinel lymph-node detection—an overview. Eur J Nucl Med 26(4 Suppl):S36–S42

    CAS  PubMed  Google Scholar 

  3. Gencoglu EA, Yalcn H, Yagmurdur M, Ozen A, Basaran O, Karakayal F et al (2005) The efficacy of 99mTc-HIG for sentinel lymph node mapping in breast cancer patients. Nucl Med Commun 26(9):781–786

    Article  PubMed  Google Scholar 

  4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398

    Article  CAS  PubMed  Google Scholar 

  5. Seok JW, Kim IJ (2008) Comparison of the efficacy for Tc-99m tin-colloid and Tc-99m phytate in sentinel node detection in breast cancer patients. Nucl Med Mol Imaging 42:451–455

    Google Scholar 

  6. Cochran AJ, Huang RR, Lee J, Itakura E, Leong SP, Essner R (2006) Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 6:659–670

    Article  CAS  PubMed  Google Scholar 

  7. Cochran AJ, Wen DR, Farzad Z, Stene MA, McBride W, Lana AM (1989) Immunosuppression by melanoma cells as a factor in the generation of metastatic disease. Anticancer Res 9:859–864

    CAS  PubMed  Google Scholar 

  8. Botella-Estrada R, Dasi F, Ramos D, Nagore E, Herrero MJ, Gimenez J et al (2005) Cytokine expression and dendritic cell density in melanoma sentinel nodes. Melanoma Res 15:99–106

    Article  CAS  PubMed  Google Scholar 

  9. Tatini VR, Dworkin HJ (2001) Fusion lymphoscintigraphy with a 24-hour Tc-99m MDP bone scan for sentinel lymph node detection and imaging. Clin Nucl Med 26:53

    Article  CAS  PubMed  Google Scholar 

  10. Huang RR, Wen DR, Guo J, Giuliano AE, Nguyen M, Offodile R et al (2000) Selective modulation of paracortical dendritic cells and t-lymphocytes in breast cancer sentinel lymph nodes. Breast J 6:225–232

    Article  PubMed  Google Scholar 

  11. Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR et al (1998) Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 82:1704–1708

    Article  CAS  PubMed  Google Scholar 

  12. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW et al (1995) Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36:1775–1780

    CAS  PubMed  Google Scholar 

  13. Gencoglu EA, Yalcn H, Yagmurdur M, Ozen A, Basaran O, Karakayal F et al (2005) The efficacy of 99mTc-HIG for sentinel lymph node mapping in breast cancer patients. Nucl Med Commun 26:781–786

    Article  PubMed  Google Scholar 

  14. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822

    Article  CAS  PubMed  Google Scholar 

  15. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP et al (1997) Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366–368

    CAS  PubMed  Google Scholar 

  16. Takei H, Suemasu K, Kurosumi M, Ninomiya J, Horii Y, Inoue K et al (2006) 99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer. Surg Today 36:219–224

    Article  CAS  PubMed  Google Scholar 

  17. Jang SJ, Moon SH, Kim SK, Kim BS, Kim SW, Chung KW et al (2007) Comparison of the results for sentinel lymph node mapping inthe breast cancer patients using 99mTc-Antimony trisulfide colloid, 99mtc-tin colloid, and 99mTc-human serum albumin. Nucl Med Mol Imaging 41:546–552

    Google Scholar 

  18. Chatterton BE, Vannitamby M, Cook DJ (1980) Lymph node visualization: an unusual artifact in the 99mTc-pyrophosphate bone scan. Eur J Nucl Med 5:187–188

    Article  CAS  PubMed  Google Scholar 

  19. Penney HF, Styles CB (1982) Fortuitous lymph node visualization after interstitial injection of Tc-99m MDP. Clin Nucl Med 7:84–85

    Article  CAS  PubMed  Google Scholar 

  20. Nour A (2004) Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients. Breast J 10:388–391

    Article  PubMed  Google Scholar 

  21. Varghese P, Abdel-Rahman AT, Akberali S, Mostafa A, Gattuso JM, Carpenter R (2008) Methylene blue dye—a safe and effective alternative for sentinel lymph node localization. Breast J 14:61–67

    Article  PubMed  Google Scholar 

  22. Varghese P, Mostafa A, Abdel-Rahman AT, Akberali S, Gattuso J, Canizales A et al (2007) Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localization in early breast cancer. Eur J Surg Oncol 33:147–152

    Article  CAS  PubMed  Google Scholar 

  23. Kapteijn BA, Nieweg OE, Liem I, Mooi WJ, Balm AJ, Muller SH et al (1997) Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 4:156–160

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by the Korea Research Foundation Grant funded by the Korean Society of Nuclear Medicine

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to You-Jung Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, YJ., Lim, SJ. & Song, JY. Tc-99m Diphosphonate as a Potential Radiotracer to Detect Sentinel Lymph Nodes in Patients with Breast Cancer. Nucl Med Mol Imaging 44, 62–68 (2010). https://doi.org/10.1007/s13139-009-0002-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-009-0002-7

Keywords

Navigation